Welcome to our dedicated page for Bunge Global SA SEC filings (Ticker: BG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bunge Global SA filings document the regulatory record of a Swiss-incorporated agribusiness company with registered shares listed on the New York Stock Exchange under BG. Its disclosures cover operating and financial results, material events, proxy governance, shareholder voting matters and capital-structure changes.
The company's recent 8-K filings include amendments to a trade receivables securitization program, executive compensation arrangements tied to integration efforts, amendments to its Articles of Association following share cancellations, and exhibits for results releases. Proxy materials address board governance, voting matters, executive compensation and other shareholder disclosures, while material-event reports also document integration and risk-related information following completed acquisitions.
Mahoney Christopher reported acquisition or exercise transactions in this Form 4 filing.
Bunge Global SA director Christopher Mahoney received an equity award tied to company stock. The filing shows a grant of 1,654 shares of common stock in the form of Restricted Stock Units, which are expected to vest in full on May 20, 2027. After this award, Mahoney directly holds 8,311 shares of Bunge common stock. This appears to be a routine director compensation grant rather than an open-market purchase or sale.
Bunge Global SA director Henry Ward Winship IV received an equity award of 1,654 Restricted Stock Units (RSUs) tied to Bunge common stock. Each RSU converts into one share, and the award is expected to vest in full on May 20, 2027. Following this grant, he holds a total of 34,463.7968 shares of common stock directly.
Lustosa de Andrade Eliane Aleixo reported acquisition or exercise transactions in this Form 4 filing.
Bunge Global SA director Eliane Aleixo Lustosa de Andrade received an equity award in the form of restricted stock units. The award covers 1,654 RSUs, each convertible into one share of Bunge common stock at no purchase price. These RSUs are expected to vest in full on May 20, 2027, subject to the award terms. Following this grant, Lustosa de Andrade holds 7,273 shares of Bunge common stock in total. This transaction reflects a compensation-related share award rather than an open-market purchase.
Bunge Global SA director Monica Houle McGurk received an equity award of 1,654 shares in the form of Restricted Stock Units. The grant was reported at a price of $0.00 per share, indicating a compensation-related award rather than a market purchase. After this grant, her direct holdings total 7,079 shares of Bunge common stock. The RSUs are expected to vest in full on May 20, 2027, at which point each unit will convert into one share of common stock if vesting conditions are satisfied.
Bunge Global SA director Mark N. Zenuk reported a new equity award and updated holdings. He received 3,308 shares of common stock as a grant described as Restricted Stock Units, with no cash paid per share. Following this award, he holds 23,994 Bunge shares directly. A separate indirect position of 6,500 shares is reported through the Zenuk Family Living Trust. The RSUs are expected to vest in full on May 20, 2027, at which point they convert one-for-one into Bunge common stock.
Isman Adrian reported acquisition or exercise transactions in this Form 4 filing.
Bunge Global SA director Adrian Isman received an equity award rather than trading shares in the market. He was granted 1,654 Restricted Stock Units, each convertible into one share of Bunge common stock, with the RSUs expected to vest in full on May 20, 2027. Following this award, Isman holds 3,311 shares of common stock directly.
Bunge Global SA director Kenneth Simril received an equity award. He was granted 1,654 shares of common stock in the form of Restricted Stock Units as compensation, rather than through an open-market purchase or sale. After this grant, he directly holds 9,805 common shares.
The RSUs are expected to vest in full on May 20, 2027, at which point each unit will convert into one share of Bunge common stock if vesting conditions are met. This filing reflects a routine director compensation award and does not indicate any discretionary buying or selling activity.
Jojo Linda P reported acquisition or exercise transactions in this Form 4 filing.
Bunge Global SA director Linda P. Jojo reported receiving an equity award linked to the company’s common stock. She was granted 1,654 Restricted Stock Units (RSUs), each convertible into one share of Bunge common stock at no cash cost to her.
The RSUs are expected to vest in full on May 20, 2027, meaning she will receive the underlying shares if the vesting conditions are met and she remains eligible. After this award, her reported direct holdings increased to 3,593 shares of Bunge common stock.
Jensen Anne reported acquisition or exercise transactions in this Form 4 filing.
Bunge Global SA director Anne Jensen reported an equity compensation grant. She received 1,654 Restricted Stock Units (RSUs), each convertible into one share of Bunge common stock, as a non-cash award. The RSUs are expected to vest in full on May 20, 2027. After this grant, Jensen holds 3,311 shares of common stock directly, reflecting routine director compensation rather than an open-market share purchase or sale.
Bunge Global SA director Walt Markus received an equity award of 1,654 shares of common stock in the form of Restricted Stock Units. Each RSU converts into one Bunge common share, and the RSUs are expected to vest in full on May 20, 2027. Following this grant, Markus holds 3,727 common shares directly.